AlerisLife Inc. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2022-09-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2022-09-30..
- Interest coverage · 12 months: Value -8.07×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2022-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2022-09-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2022-09-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | -8.07× | Operating income ÷ reported interest expense. $-32.78M ÷ $4.06M ≈ -8.07× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | |
| Stock-based compensation | 1.57M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -32.78M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 4.06M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | (m) | (m) | $1.57M | $-32.78M | $4.06M | (m) | (m) | -8.07× | Reported |
| 2022-06-30 | (m) | (m) | $1.52M | $-32.16M | $3.09M | (m) | (m) | -10.39× | Reported |
| 2022-03-31 | (m) | (m) | $1.58M | $-37.83M | $2.25M | (m) | (m) | -16.80× | Reported |
| 2021-12-31 | (m) | (m) | $1.48M | $-25.86M | $1.68M | (m) | (m) | -15.36× | Reported |
| 2021-09-30 | (m) | (m) | $949.00K | $-13.05M | $1.84M | (m) | (m) | -7.09× | Reported |
| 2021-06-30 | (m) | (m) | $938.00K | $-2.67M | $1.71M | (m) | (m) | -1.56× | Reported |
| 2021-03-31 | (m) | (m) | $508.00K | $10.98M | $1.71M | (m) | (m) | 6.41× | Reported |
| 2020-12-31 | (m) | (m) | $513.00K | $15.94M | $1.63M | (m) | (m) | 9.77× | Reported |
| 2020-09-30 | (m) | (m) | $462.00K | $29.50M | $1.59M | (m) | (m) | 18.56× | Reported |
| 2020-06-30 | (m) | $1.29B | $492.00K | $17.80M | $1.59M | (m) | 0.04% | 11.17× | Reported |
| 2020-03-31 | (m) | $1.36B | $422.00K | $20.19M | $2.09M | (m) | 0.03% | 9.65× | Reported |
| 2019-12-31 | (m) | $1.42B | $439.00K | $-20.27M | $2.62M | (m) | 0.03% | -7.75× | Reported |
| 2019-09-30 | (m) | $1.42B | $264.00K | $-57.72M | $3.44M | (m) | 0.02% | -16.77× | Reported |
| 2019-06-30 | (m) | $1.41B | $347.00K | $-72.24M | $3.52M | (m) | 0.02% | -20.51× | Reported |
| 2019-03-31 | (m) | $1.40B | $502.00K | $-96.22M | $3.22M | (m) | 0.04% | -29.87× | Reported |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $1.39B | $964.00K | $-53.40M | $2.88M | (m) | 0.07% | -18.53× | Reported |
| 2018-06-30 | (m) | $1.38B | $1.03M | $-36.80M | $3.55M | (m) | 0.07% | -10.35× | Reported |
| 2018-03-31 | (m) | $1.39B | $1.08M | $-24.17M | $4.03M | (m) | 0.08% | -5.99× | Reported |
| 2017-12-31 | (m) | $1.40B | $1.09M | $-23.05M | $4.31M | (m) | 0.08% | -5.35× | Reported |
| 2017-09-30 | (m) | $1.39B | $1.23M | $-25.21M | $4.16M | (m) | 0.09% | -6.07× | Reported |
| 2017-06-30 | (m) | $1.39B | $1.21M | $-25.37M | $3.96M | (m) | 0.09% | -6.41× | Reported |
| 2017-03-31 | (m) | (m) | $1.20M | (m) | $4.39M | (m) | (m) | (m) | Reported |
| 2016-12-31 | (m) | $1.38B | $1.19M | $-15.97M | $4.91M | (m) | 0.09% | -3.25× | Reported |
| 2016-09-30 | (m) | $1.38B | $1.42M | $-15.40M | $5.29M | (m) | 0.10% | -2.91× | Reported |
| 2016-06-30 | (m) | $1.38B | $1.37M | $-34.90M | $5.45M | (m) | 0.10% | -6.41× | Reported |
| 2016-03-31 | (m) | (m) | $1.54M | (m) | $5.07M | (m) | (m) | (m) | Reported |
| 2015-12-31 | (m) | $1.37B | $1.62M | $-37.02M | $4.93M | (m) | 0.12% | -7.51× | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $1.33B | (m) | $-19.18M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $1.30B | (m) | $10.08M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | $5.46M | (m) | (m) | (m) | Reported |
| 2013-06-30 | (m) | (m) | (m) | (m) | $6.05M | (m) | (m) | (m) | Reported |
| 2013-03-31 | (m) | (m) | (m) | (m) | $6.30M | (m) | (m) | (m) | Reported |
| 2012-12-31 | (m) | (m) | (m) | (m) | $6.27M | (m) | (m) | (m) | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | $6.30M | (m) | (m) | (m) | Reported |
| 2012-06-30 | (m) | (m) | (m) | (m) | $5.58M | (m) | (m) | (m) | Reported |
| 2012-03-31 | (m) | (m) | (m) | (m) | $4.84M | (m) | (m) | (m) | Reported |
| 2011-12-31 | (m) | $1.06B | (m) | $16.50M | $3.92M | (m) | (m) | 4.21× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $991.20M | $1.06M | $25.33M | $2.60M | (m) | 0.11% | 9.75× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.14B | $524.00K | $10.53M | $3.93M | (m) | 0.05% | 2.68× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.